[Two new drugs. Recombinant "human" erythropoietin (EPO: Erypo, Recormon)].
Verwiebe
R
R
Abteilung Nephrologie und Rheumatologie, Universität Göttingen.
D004920:Erythropoiesis / Q000187:drug effects; D004921:Erythropoietin / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood / Q000628:therapy*; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use*; D006435:Renal Dialysis
D011994:Recombinant Proteins; D004921:Erythropoietin
Zwei neue Arzneimittel. Rekombinantes "humanes" Erythropoietin (EPO: Erypo, Recormon).